News
FRIDAY, July 18, 2025 (HealthDay News) — After years of legal battles and health concerns, Juul Labs has the go-ahead to sell ...
Juul Labs said today the U.S. Food and Drug Administration has authorized the sale of its e-cigarette device and refill ...
The U.S. Food and Drug Administration has approved Juul's original vaporizer and refill cartridges in tobacco and menthol ...
FDA regulators said Juul's studies show its e-cigarettes are less harmful for adult smokers, who can benefit from switching ...
FDA regulators said Thursday that Juul’s studies show its e-cigarettes are less harmful for adult smokers, who can benefit ...
Federal health officials will allow Juul to keep selling its electronic cigarettes. The Food and Drug Administration said ...
The U.S. Food and Drug Administration has authorized the sale of Juul's e-cigarette device and refill cartridges in tobacco ...
The House approved President Donald Trump's request to slash $9 billion in spending; a poll reveals most people believe the ...
How nicotine pouches are causing a rise in poisoning cases among young children and what parents can do to prevent it ...
The House approved President Donald Trump's request to slash $9 billion in spending; a poll reveals most people believe the ...
The FDA has approved the interferon gamma-blocking antibody emapalumab -lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS) in known or suspected Still disease.
The FDA has approved Gamifant as the first-ever treatment for macrophage activation syndrome in Still’s disease for adults and children who have an inadequate response or intolerance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results